Literature DB >> 16530999

Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response.

Sylvia Fitting1, Rosemarie M Booze, Charles F Mactutus.   

Abstract

The current estimate of children (<15 years) living with HIV and AIDS is 2.2 million. The major source of infection occurs through vertical transmission of the virus from mother to child during delivery [UNAIDS/WHO, 2005. AIDS Epidemic Update. UNAIDS, Geneva]. Recent studies have shown that timing of HIV-1 infection might be related to the onset and rate of progression of CNS disease. The effects of HIV on the brain are thought to be mediated indirectly through the viral toxins Tat and gp120. This study characterized developmental effects on PPI following intrahippocampal administration of Tat. On postnatal day (P)1, one male and one female pup from each of eight Sprague-Dawley litters were bilaterally injected with 50 microg Tat or saline (1 microl volume). Animals were tested for PPI of the auditory startle response (ASR) (ISIs of 0, 8, 40, 80, 120, and 4000 ms, six trial blocks, Latin-square design) on days 30, 60 and 90. Tat altered PPI and the pattern of alterations was different for males and females. For males, a leftward shift was evident in the ISI for maximal inhibition of the response on day 30 and on day 60 (chi(2)(1)=4.7, p< or =.03, and chi(2)(1)=5.3, p< or =.02, respectively), but not on day 90. For females, Tat altered peak ASR latency across PPI trials (8-120 ms) at all days of testing (30, 60, and 90 days of age), as indexed by orthogonal component analyses, indicating less modulation of PPI by ISI. Data collected from a second group that were tested only once at 90 days of age, suggested that the observed adverse Tat effects for males and females early in development were maintained with age. Thus, the diminishing TAT effect on PPI at day 90 in a longitudinal study design was attributed to repeated testing, rather than 'recovery of function'. Collectively, the data suggested that hippocampal Tat injections in neonatal rats produced alterations in the pre-attentive process of sensorimotor gating, as indexed by PPI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530999      PMCID: PMC4042027          DOI: 10.1016/j.ijdevneu.2006.02.001

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  41 in total

1.  Intrahippocampal injections of Tat: effects on prepulse inhibition of the auditory startle response in adult male rats.

Authors:  Sylvia Fitting; Rosemarie M Booze; Ulla Hasselrot; Charles F Mactutus
Journal:  Pharmacol Biochem Behav       Date:  2006-06-21       Impact factor: 3.533

2.  Neurotological auditory brain stem response findings in human immunodeficiency virus-positive patients without neurologic manifestations.

Authors:  E Castello; N Baroni; E Pallestrini
Journal:  Ann Otol Rhinol Laryngol       Date:  1998-12       Impact factor: 1.547

3.  Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input.

Authors:  H S Hoffman; J R Ison
Journal:  Psychol Rev       Date:  1980-03       Impact factor: 8.934

4.  Menstrual cycle phase effects on prepulse inhibition of acoustic startle.

Authors:  Tanja Jovanovic; Sandor Szilagyi; Subhajit Chakravorty; Ana M Fiallos; Barbara J Lewison; Arti Parwani; Marion P Schwartz; Stephen Gonzenbach; John P Rotrosen; Erica J Duncan
Journal:  Psychophysiology       Date:  2004-05       Impact factor: 4.016

5.  Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain.

Authors:  Annadora J Bruce-Keller; Ashok Chauhan; Filomena O Dimayuga; Jillian Gee; Jeffrey N Keller; Avindra Nath
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

Review 6.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

7.  HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region.

Authors:  Thomas Behnisch; Walter Francesconi; Pietro Paolo Sanna
Journal:  Brain Res       Date:  2004-06-25       Impact factor: 3.252

8.  Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery.

Authors:  S Blanche; M J Mayaux; C Rouzioux; J P Teglas; G Firtion; F Monpoux; N Ciraru-Vigneron; F Meier; J Tricoire; C Courpotin
Journal:  N Engl J Med       Date:  1994-02-03       Impact factor: 91.245

9.  Delayed latency of the event-related brain potential P3A component in HIV disease. Progressive effects with increasing cognitive impairment.

Authors:  G Fein; C A Biggins; S MacKay
Journal:  Arch Neurol       Date:  1995-11

10.  Behavioral effects of psychomotor stimulants in rats with dorsal or ventral subiculum lesions: locomotion, cocaine self-administration, and prepulse inhibition of startle.

Authors:  S B Caine; T Humby; T W Robbins; B J Everitt
Journal:  Behav Neurosci       Date:  2001-08       Impact factor: 1.912

View more
  25 in total

1.  Neonatal intrahippocampal gp120 injection: an examination early in development.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Neurotoxicology       Date:  2006-07-31       Impact factor: 4.294

2.  Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat.

Authors:  Katy M Webb; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

3.  Temporal processsing demands in the HIV-1 transgenic rat: Amodal gating and implications for diagnostics.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2016-12-28       Impact factor: 2.457

4.  Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.

Authors:  Jason J Paris; Harminder D Singh; Amanda N Carey; Jay P McLaughlin
Journal:  Behav Brain Res       Date:  2015-05-22       Impact factor: 3.332

5.  Diagnostic and prognostic biomarkers for HAND.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2019-01-03       Impact factor: 2.643

6.  Neurotoxicity of HIV-1 Tat protein: involvement of D1 dopamine receptor.

Authors:  Janelle M Silvers; Marina V Aksenova; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurotoxicology       Date:  2007-07-22       Impact factor: 4.294

7.  Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.

Authors:  Brook L Henry; Mark A Geyer; Mahalah R Buell; William Perry; Jared W Young; Arpi Minassian
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

8.  A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat.

Authors:  Kristen A McLaurin; Landhing M Moran; Hailong Li; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neuroimmune Pharmacol       Date:  2016-10-03       Impact factor: 4.147

Review 9.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

10.  Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Brain Res       Date:  2008-07-17       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.